CIMT

CIMT - Ausbildungs- und Netzwerkplattform für individualisierte Immunintervention Schlussbericht : Laufzeit des Vorhabens: 01.10.2012-31.03.2017 = CIMT - Education and networking platform for individualized immune intervention by Christoph Huber( )

1 edition published in 2017 in German and held by 7 WorldCat member libraries worldwide

CIMT 2013 : advancing targeted therapies-report on the 11th annual meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany( )

1 edition published in 2013 in English and held by 1 WorldCat member library worldwide

Toward the next waves of cancer immunotherapy : 11th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013( )

1 edition published in 2014 in English and held by 1 WorldCat member library worldwide

Quarterly Newsletter by International Commission on Occupational Health( )

in Multiple languages and held by 1 WorldCat member library worldwide

Cancer immunotherapy meets oncology by Cedrik Michael Britten( Book )

1 edition published in 2014 in English and held by 1 WorldCat member library worldwide

This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing. Cancer Immunotherapy Meets Oncology is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients